|
1HE1
Crystal structure of the complex between the GAP domain of the Pseudomonas aeruginosa ExoS toxin and human Rac
Deposited 2000-11-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
95–229(135 aa)
Fragment:96-234, GTPASE-ACTIVATING PROTEIN (GAP-DOMAIN)
|
Not recorded
|
NI NICKEL (II) ION × 3
GDP GUANOSINE-5'-DIPHOSPHATE × 1
AF3 ALUMINUM FLUORIDE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;8% PEG 6000, 3MM NICL2, 100 MM TRIS/HCL PH8.5, pH 8.50
|
Resolution 2.00 Å
R-free 0.224
|
|
1HE1
Crystal structure of the complex between the GAP domain of the Pseudomonas aeruginosa ExoS toxin and human Rac
Deposited 2000-11-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
95–229(135 aa)
Fragment:96-234, GTPASE-ACTIVATING PROTEIN (GAP-DOMAIN)
|
Not recorded
|
NI NICKEL (II) ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
AF3 ALUMINUM FLUORIDE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;8% PEG 6000, 3MM NICL2, 100 MM TRIS/HCL PH8.5, pH 8.50
|
Resolution 2.00 Å
R-free 0.224
|
|
2C23
14-3-3 Protein Beta (Human) in complex with exoenzyme S peptide
Deposited 2005-09-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain P
421–431(11 aa)
Fragment:14-3-3 BINDING REGION, RESIDUES 421-431
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.05M MGCL2,0.1M HEPES PH7.5, 30% PEG MME 550, pH 8.00
|
Resolution 2.65 Å
R-free 0.286
|
|
6GN0
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, tetrameric crystal form
Deposited 2018-05-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
234–453(220 aa)
Chain G
234–453(220 aa)
|
Mutation:E379A, E381A
Mutation:E379A, E381A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;277 K;12% PEG 3350, 4% Tacsimate
|
Resolution 3.24 Å
R-free 0.294
|
|
6GN0
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, tetrameric crystal form
Deposited 2018-05-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain F
234–453(220 aa)
Chain H
234–453(220 aa)
|
Mutation:E379A, E381A
Mutation:E379A, E381A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;277 K;12% PEG 3350, 4% Tacsimate
|
Resolution 3.24 Å
R-free 0.294
|
|
6Y7T
Engineered conjugation of lysine-specific molecular tweezers with ExoS derived peptidic inhibitor enhance affinity towards target protein 14-3-3 through ditopic binding
Deposited 2020-03-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: TRIMERIC
|
Chain D
420–430(11 aa)
|
Not recorded
|
NA SODIUM ION × 3
GOL GLYCEROL × 1
TWZ 2-[4-[2-[hydroxy-[[(1R,5S,9S,16R,20R,24S,28S,35R)-22-phosphonooxy-3-tridecacyclo[22.14.1.15,20.19,16.128,35.02,23.04,21.06,19.08,17.010,15.025,38.027,36.029,34]dotetraconta-2,4(21),6(19),7,10,12,14,17,22,25(38),26,29,31,33,36-pentadecaenyl]oxy]phosphoryl]oxyethyl]triazol-1-yl]acetic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;Bis-Tris Propane
0.2M sodium acetate trihydrate
20% PEG1000
10% Glycerol
pH 7
Grew at 4 degree Celsius after a few days
|
Resolution 2.50 Å
R-free 0.268
|
|
6Y7T
Engineered conjugation of lysine-specific molecular tweezers with ExoS derived peptidic inhibitor enhance affinity towards target protein 14-3-3 through ditopic binding
Deposited 2020-03-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: TRIMERIC
|
Chain E
420–430(11 aa)
|
Not recorded
|
NA SODIUM ION × 2
GOL GLYCEROL × 1
TWZ 2-[4-[2-[hydroxy-[[(1R,5S,9S,16R,20R,24S,28S,35R)-22-phosphonooxy-3-tridecacyclo[22.14.1.15,20.19,16.128,35.02,23.04,21.06,19.08,17.010,15.025,38.027,36.029,34]dotetraconta-2,4(21),6(19),7,10,12,14,17,22,25(38),26,29,31,33,36-pentadecaenyl]oxy]phosphoryl]oxyethyl]triazol-1-yl]acetic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;Bis-Tris Propane
0.2M sodium acetate trihydrate
20% PEG1000
10% Glycerol
pH 7
Grew at 4 degree Celsius after a few days
|
Resolution 2.50 Å
R-free 0.268
|